News Center

Home page

Peak Report

News reports

Announcement on the Holding Subsidiary's Obtaining of the "Drug GMP Certificate"

Release time:

2021-05-20

Securities Code: 600668 Securities Abbreviation: Jianfeng Group Announcement No.: Pro 2019-034

Bond Abbreviation: 13 Peak 02 Bond Code: 122344

Zhejiang Jianfeng Group Co., Ltd.

Announcement

on the Obtaining of "GMP Certificate" by the Holding Subsidiary The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and shall bear individual and joint liabilities

for the authenticity, accuracy and completeness of its contents.

Recently, Zhejiang Jianfeng Group Co., Ltd. (hereinafter referred to as "the company") holding subsidiary Zhejiang Jianfeng Pharmaceutical Co., Ltd. (hereinafter referred to as "Jianfeng Pharmaceutical")

received the "Drug GMP Certificate" issued by Zhejiang Food and Drug Administration. The relevant information is hereby announced as follows:

1. GMP

Certification Related Information

Enterprise Name: Zhejiang Jianfeng Pharmaceutical Co., Ltd.

Address: No. 58

Certificate No.: ZJ20190116

Certification Scope: powder injection (including cephalosporins) and freeze-dried powder injection

certification date: 2019

10 31

valid: 2024

10 30

2. GMP

Certificate Involving Production Line

Production Line Name

Design Annual Capacity

Main Variety

Powder Injection Production Line

about 2000

cefmenoxime hydrochloride for injection,

cefoxitin sodium for injection

freeze-dried powder injection production line

about 1000

penciclovir for injection,

for injection ribavirin

Main Information of 3. Products

Drug Name	Dosage Form	Therapeutic Field	Manufacturer
Injection Cefmenoxime Hydrochloride	Powder Injection (Including Cephalosporins)	Anti-infection	Shanghai Shangyao Xinya Pharmaceutical Co., Ltd., Liaoning Haisco Pharmaceutical Co., Ltd., Hainan Tianhuang Pharmaceutical Co., Ltd., Hainan Lingkang Pharmaceutical Co., Ltd. and Jianfeng Pharmaceutical Co., Ltd. and other 10 .
Injection Cefoxitin Sodium	Powder Injection (Including Cephalosporins)	Anti-infection	Harbin Pharmaceutical Group Pharmaceutical General Factory, Guangdong Bozhou Pharmaceutical Co., Ltd., Sichuan Pharmaceutical Preparation Co., Ltd., Shandong Luoxin Pharmaceutical Group Co., Ltd. and Jianfeng Pharmaceutical Co., etc. 49 home.
Penciclovir for Injection	Freeze-dried Powder Injection	Antivirus	Ruiyang Pharmaceutical Co., Ltd. and Jianfeng Pharmaceutical .
Ribavirin for Injection	Freeze-dried Powder Injection	Antivirus	Shanghai Shangyao Xinya Pharmaceutical Co., Ltd., Zhejiang Asia Pacific Pharmaceutical Co., Ltd., Haikou Qili Pharmaceutical Co., Ltd., Hainan General Kangli Pharmaceutical Co., Ltd. and Jianfeng Pharmaceutical Co., Ltd. 209 7 .

Note: 1

, "Major Manufacturers " information in the above table mainly comes from the website of china food and drug administration;

4. Impact on Listed Companies and Risk Tips

The "GMP

Certificate" obtained by Jianfeng Pharmaceutical Co., Ltd. this time is that its original GMP certificate for powder injection and freeze-dried powder injection production line expires and obtains the certificate after re-certification. Re-obtaining the GMP certificate will help ensure the production capacity of the above-mentioned products and ensure the continuity of market supply. It will not have a significant impact on the Company's current operations. The future sales of various drugs of

Company may be affected by the market environment, industry policies, supply and demand and other factors, with certain uncertainties. Please the majority of investors cautious decision-making, pay attention to prevent investment risk.

hereby announce

Zhejiang Jianfeng Group Co., Ltd.

Board of Directors

November 6

, 2019

More information

The company's vocational skill level independently identifies two new occupations

A few days ago, after the examination and approval of the Jinhua Municipal Bureau of Human Resources and Social Security, and reported to the Provincial Department of Human Resources and Social Security for examination and filing, Jianfeng Group's independent identification level of vocational skills was based on last year. Two new occupations (types of work) are chemical inspectors and organic synthesis workers.

2022

05-20

Cai Xiaochun, deputy secretary of the Party Group of the Provincial Federation of Industry and Commerce, went to the peak to investigate.

On May 12, Cai Xiaochun, deputy secretary of the Party group of Zhejiang Federation of industry and commerce, and his party visited Jianfeng group for investigation, visited Jinxi factory area of Jianfeng pharmaceutical factory and Jinxi internationalization project site, and had a discussion with Jiang Xiaomeng, chairman of the group company, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company.

2022

05-20

Reduce costs, re-standardize, for enterprises to empower Jiang Xiaomeng "two sessions night talk" on Jinhua enterprise development

On the afternoon of April 6, Jiang Xiaomeng, chairman of the group company, was invited to participate in the Jinhua News Client Financial Media Interview column "Night Talk of the Two Sessions", as a representative of the Jinhua Municipal People's Congress, to talk about suggestions for the future development of Jinhua enterprises. As the chairman of the Jinhua City Federation of Industry and Commerce, Jiang Xiaomeng has a personal experience of various problems encountered in the development of Jinhua enterprises. After careful investigation and full preparation, he put forward two proposals on strengthening the empowerment and allocation of production factors and further enhancing the market competitiveness of enterprises in our city and further promoting the compliance construction of private enterprises in our city and reducing the risk of enterprise operation. In the "two sessions night talk" interview, he put forward his own views on these two topics.

2022

04-12

Group Companies Commend 2021 Advanced

On the morning of January 26, the group company held the 2021 annual summary commendation meeting to review the work of the previous year, make arrangements for the work of 2022, sign the 2022 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2021 advanced collectives and individuals.

2022

02-08

Group Company Convenes Workers' Representative and Trade Union Member Representative Conference

The group company held a representative meeting of staff representatives and trade union members, elected members of the eighth trade union committee and members of various special committees, and Shi Fu was elected chairman of the eighth trade union of the group trade union.

2022

02-08

The group company held an annual safety and environmental protection work conference and proposed to establish the concept of "every team leader is the first responsible person for safety"

The group company held an annual safety and environmental protection work conference to comprehensively summarize and review the safety and environmental protection work in 2021, make arrangements for the safety and environmental protection work in 2022, and sign the safety and environmental protection work responsibility system.

2022

02-08

< 1...6 7 8...61 > 跳转到页